Structure Database (LMSD)

Introduction | Text/ontology-based search | Structure-based search | Programmatic Access

LMSD: Lipid classification search results

Sphingolipids [SP] (W) --> Neutral glycosphingolipids [SP05]--> Simple Glc series [SP0501]
LM_IDCommon NameSystematic NameFormulaMass
LMSP05010031Glucosyl sphingosine1-β-glucosyl-sphing-4-enineC24H47NO7461.3353
LMSP05010032FMC-5(d18:1/18:0)N-(octadecanoyl)-1-β-(2',3',4',6'-
tetra-O-acetyl-galactosyl)-3-O-acetyl-
sphing-4-enine
C52H91NO13937.6490
LMSP05010033FMC-5(d18:1/20:0)N-(eicosanoyl)-1-β-(2',3',4',6'-tetra-
O-acetyl-galactosyl)-3-O-acetyl-sphing-
4-enine
C54H95NO13965.6803
LMSP05010034FMC-5(d18:1/22:0)N-(docosanoyl)-1-β-(2',3',4',6'-tetra-
O-acetyl-galactosyl)-3-O-acetyl-sphing-
4-enine
C56H99NO13993.7116
LMSP05010035FMC-5(d18:1/24:0)N-(tetracosanoyl)-1-β-(2',3',4',6'-
tetra-O-acetyl-galactosyl)-3-O-acetyl-
sphing-4-enine
C58H103NO131021.7429
LMSP05010036FMC-5(d18:1/24:1)N-(15Z-tetracosenoyl)-1-β-(2',3',4',6'-
tetra-O-acetyl-galactosyl)-3-O-acetyl-
sphing-4-enine
C58H101NO131019.7273
LMSP05010037FMC-6(d18:1/24:0(2-OH))N-(2-hydroxy-tetracosanoyl)-1-β-(2',3',
4',6'-tetra-O-acetyl-galactosyl)-3-O-
acetyl-sphing-4-enine
C58H103NO141037.7379
LMSP05010038FMC-6(d18:1/22:0(2-OH))N-(2-hydroxy-docosanoyl)-1-β-(2',3',4',
6'-tetra-O-acetyl-galactosyl)-3-O-
acetyl-sphing-4-enine
C56H99NO141009.7066
LMSP05010039Phalluside-1N-(2R-hydroxy-hexadecanoyl)-1-β-
glucosyl-9-methyl-sphing-4E,8E,10E-
trienine
C41H75NO9725.5442
LMSP0501AA00GlcCer (W)Glcβ-Cer--
LMSP0501AA01GlcCer(d18:1/12:0)N-(dodecanoyl)-1-β-glucosyl-sphing-4-
enine
C36H69NO8643.5023
LMSP0501AA03GlcCer(d18:1/16:0)N-(hexadecanoyl)-1-β-glucosyl-sphing-4-
enine
C40H77NO8699.5649
LMSP0501AA04GlcCer(d18:0/16:0)N-(hexadecanoyl)-1-β-glucosyl-
sphinganine
C40H79NO8701.5806
LMSP0501AA05GlcCer(d18:1/18:0)N-(octadecanoyl)-1-β-glucosyl-sphing-4-
enine
C42H81NO8727.5962
LMSP0501AA06GlcCer(d18:1/20:0)N-(eicosanoyl)-1-β-glucosyl-sphing-4-
enine
C44H85NO8755.6275
LMSP0501AA07GlcCer(d18:1/22:0)N-(docosanoyl)-1-β-glucosyl-sphing-4-
enine
C46H89NO8783.6588
LMSP0501AA08GlcCer(d18:1/24:1(15Z))N-(15Z-tetracosenoyl)-1-β-glucosyl-
sphing-4-enine
C48H91NO8809.6745
LMSP0501AA09GlcCer(d18:1/24:0)N-(tetracosanoyl)-1-β-glucosyl-sphing-
4-enine
C48H93NO8811.6901
LMSP0501AA10GlcCer(d18:1/26:1(17Z))N-(17Z-hexacosenoyl)-1-β-glucosyl-
sphing-4-enine
C50H95NO8837.7058
LMSP0501AA11GlcCer(d18:1/26:0)N-(hexacosanoyl)-1-β-glucosyl-sphing-4-
enine
C50H97NO8839.7214
LMSP0501AA19GlcCer(d18:0/18:0)N-(octadecanoyl)-1-β-glucosyl-
sphinganine
C42H83NO8729.6119
LMSP0501AA20GlcCer(d18:0/20:0)N-(eicosanoyl)-1-β-glucosyl-sphinganineC44H87NO8757.6432
LMSP0501AA21GlcCer(d18:0/22:0)N-(docosanoyl)-1-β-glucosyl-sphinganineC46H91NO8785.6745
LMSP0501AA22GlcCer(d18:0/24:1(15Z))N-(15Z-tetracosenoyl)-1-β-glucosyl-
sphinganine
C48H93NO8811.6901
LMSP0501AA23GlcCer(d18:0/24:0)N-(tetracosanoyl)-1-β-glucosyl-
sphinganine
C48H95NO8813.7058
LMSP0501AA24GlcCer(d18:0/26:1(17Z))N-(17Z-hexacosenoyl)-1-β-glucosyl-
sphinganine
C50H97NO8839.7214
LMSP0501AA25GlcCer(d18:0/26:0)N-(hexacosanoyl)-1-β-glucosyl-
sphinganine
C50H99NO8841.7371
LMSP0501AA26GlcCer(d18:1/14:0)N-(tetradecanoyl)-1-β-glucosyl-sphing-
4-enine
C38H73NO8671.5336
LMSP0501AA27GlcCer(d18:1/18:1(9Z))N-(9Z-octadecenoyl)-1-β-glucosyl-
sphing-4-enine
C42H79NO8725.5806
LMSP0501AA28GlcCer(d18:0/14:0)N-(tetradecanoyl)-1-β-glucosyl-
sphinganine
C38H75NO8673.5493
LMSP0501AA29GlcCer(d18:0/18:1(9Z))N-(9Z-octadecenoyl)-1-β-glucosyl-
sphinganine
C42H81NO8727.5962
LMSP0501AA30GlcCer(d16:1/22:0)N-(docosanoyl)-1-β-glucosyl-
hexadecasphing-4-enine
C44H85NO8755.6275
LMSP0501AA31GlcCer(d16:1/23:0)N-(tricosanoyl)-1-β-glucosyl-
hexadecasphing-4-enine
C45H87NO8769.6432
LMSP0501AA32GlcCer(d18:1/23:0)N-(tricosanoyl)-1-β-glucosyl-sphing-4-
enine
C47H91NO8797.6745
LMSP0501AA33GlcCer(d18:2/16:0)N-(hexadecanoyl)-1β-glucosyl-4E,14Z-
sphingadienine
C40H75NO8697.5493
LMSP0501AA34GlcCer(d18:2/20:0)N-(eicosanoyl)-1β-glucosyl-4E,14Z-
sphingadienine
C44H83NO8753.6119
LMSP0501AA35GlcCer(d18:2/20:1)N-(11Z-eicosenoyl)-1β-glucosyl-4E,14Z-
sphingadienine
C44H81NO8751.5962
LMSP0501AA36GlcCer(d18:2/21:0)N-(heneicosanoyl)-1β-glucosyl-4E,14Z-
sphingadienine
C45H85NO8767.6275
LMSP0501AA37GlcCer(d18:2/22:0)N-(docosanoyl)-1β-glucosyl-4E,14Z-
sphingadienine
C46H87NO8781.6432
LMSP0501AA38GlcCer(d18:2/23:0)N-(tricosanoyl)-1β-glucosyl-4E,14Z-
sphingadienine
C47H89NO8795.6588
LMSP0501AA39GlcCer(d14:1/16:0)N-(hexadecanoyl)-1-β-glucosyl-
tetradecasphing-4-enine
C36H69NO8643.5023
LMSP0501AA40GlcCer(d14:1/18:0)N-(octadecanoyl)-1-β-glucosyl-
tetradecasphing-4-enine
C38H73NO8671.5336
LMSP0501AA41GlcCer(d14:1/18:1)N-(9Z-octadecenoyl)-1-β-glucosyl-
tetradecasphing-4-enine
C38H71NO8669.5180
LMSP0501AA42GlcCer(d14:1/20:0)N-(eicosanoyl)-1-β-glucosyl-
tetradecasphing-4-enine
C40H77NO8699.5649
LMSP0501AA43GlcCer(d14:1/22:0)N-(docosanoyl)-1-β-glucosyl-
tetradecasphing-4-enine
C42H81NO8727.5962
LMSP0501AA44GlcCer(d14:1/24:0)N-(tetracosanoyl)-1-β-glucosyl-
tetradecasphing-4-enine
C44H85NO8755.6275
LMSP0501AA45GlcCer(d14:1/24:1)N-(15Z-tetracosenoyl)-1-β-glucosyl-
tetradecasphing-4-enine
C44H83NO8753.6119
LMSP0501AA46GlcCer(d15:1/18:0)N-(octadecanoyl)-1-β-glucosyl-
pentadecasphing-4-enine
C39H75NO8685.5493
LMSP0501AA47GlcCer(d15:1/20:0)N-(eicosanoyl)-1-β-glucosyl-
pentadecasphing-4-enine
C41H79NO8713.5806
LMSP0501AA48GlcCer(d15:1/22:0)N-(docosanoyl)-1-β-glucosyl-
pentadecasphing-4-enine
C43H83NO8741.6119

Showing page 1 of 3     Results:    1  2  3  Next     Showing results 1 to 50 of 140

   

logo LIPID MAPS is funded by a Wellcome Trust.